Menu
My Activity Hub
Podcasts
Videos
Pricing
Feedback
Tutoring
Sign Up
Log In
My Activity Hub
Podcasts
Videos
How it works
Pricing
Tutoring
Sign Up
Log In
OncLive® On Air
Lunning and Kamdar Debate the Role of Pola-R-CHP in Treatment-NaĂŻve DLBCL
20 mins; July 24, 2023
Khan and Kwendakwema Discuss Financial Toxicity in Patients With Cancer
12 mins; July 20, 2023
FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC
13 mins; July 17, 2023
Lunning and Abramson Spotlight Developments and Challenges in LBCL Research and Management
32 mins; July 13, 2023
FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis
13 mins; July 10, 2023
King Describes Unmet Needs and the Role of Surgical Resection in Residual Non-RP Testicular Cancer
10 mins; July 06, 2023
Kremyanskaya Highlights the Benefits of BET Inhibitors in Myelofibrosis
12 mins; July 03, 2023
Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023
13 mins; June 29, 2023
Camidge and Cetnar Revisit ASCO 2023 Data in Lung Cancer
50 mins; June 26, 2023
Manana Discusses Systemic Racism in Oncology and Future Steps for Equitable Cancer Care
15 mins; June 22, 2023
Reuss Reviews the Development of LP-300 in Advanced NSCLC
10 mins; June 19, 2023
FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC
12 mins; June 15, 2023
FDA Approval Insights: Epcoritamab in Relapsed/Refractory DLBCL
11 mins; June 12, 2023
Holowatyj Highlights Challenges and Opportunities in Appendix Cancer Research
15 mins; June 08, 2023
Raskin Reflects on the Career-Long Role of Fellowship and Education in Orthopaedic Oncology
18 mins; June 05, 2023
Camidge and Weickhardt Consider Oncology Practice and Patient Care From an International Perspective
38 mins; June 01, 2023
Andreeff Sheds Light on the Evaluation of the E-selectin Antagonist Uproleselan in AML
21 mins; May 29, 2023
Gottschalk and Krenciute Discuss the Development of CAR T-cell Therapy in Pediatric Solid Tumors
24 mins; May 25, 2023
Mutale Discusses Disparities in Cancer Clinical Trial Eligibility, Access and Enrollment
14 mins; May 22, 2023
Oncology Professionals Explain the Nuances of Career-Building Mentorship and Self-Advocacy
19 mins; May 18, 2023
FDA Approval Insights: Omidubicel in Blood Cancers Requiring Transplant
9 mins; May 15, 2023
Haffner Highlights Treatment and Research Considerations for Basal Cell Carcinoma of the Prostate
12 mins; May 11, 2023
Ehrhardt Explains the Effects of Modifiable Health Conditions on Late Mortality for Childhood Cancer Survivors
13 mins; May 08, 2023
Camidge and Turner Reflect on the Importance of Care and Connection Throughout the Cancer Journey
45 mins; May 04, 2023
Stand Up to Cancer Grant Recipients Discuss Initiative to Expand Access to Early-Phase Clinical Trials
40 mins; May 01, 2023
Kim Discusses the Development of LP-300 Plus Chemotherapy in Advanced Lung Cancer
9 mins; April 27, 2023
FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Urothelial Carcinoma
18 mins; April 24, 2023
Gushchin and Diaz-Montes Describe QOL Outcomes After Cytoreduction and HIPEC in Ovarian Cancer
12 mins; April 20, 2023
Desai Discusses the Significance of a Supportive, Foundational Fellowship Experience
13 mins; April 17, 2023
FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer
13 mins; April 13, 2023
Gynecologic Cancer Experts Review 2023 SGO Research and Treatment Updates
22 mins; April 10, 2023
Mercado and Kovacs Emphasize the Importance of Multidisciplinary Lung Cancer Screening and Management
26 mins; April 06, 2023
Kishan Discusses GI Toxicity Reduction With MRI-Guided SBRT in Prostate Cancer
16 mins; April 03, 2023
FDA Approval Insights: Elacestrant in ER+/HER2– ESR1-mutated Advanced or Metastatic Breast Cancer
10 mins; March 30, 2023
Breast Cancer Experts Review 2023 MBCC Research Updates and the Importance of Multidisciplinary Collaboration
43 mins; March 27, 2023
Camidge and Jalal on Setting up an Infrastructure for Success in Life and Work
29 mins; March 23, 2023
FDA Approval Insights: Sacituzumab Govitecan in HR-positive, HER2-negative Breast Cancer
7 mins; March 20, 2023
Raez Reports Benefits of Liquid Biopsy in Newly Diagnosed NSCLC
13 mins; March 16, 2023
Milner, Dalal, and Ligon Discuss Stem Cell Transplant Methods, Results, and Risk Factors in Pediatric Patients
15 mins; March 13, 2023
FDA Approval Insights: Adjuvant Pembrolizumab in Stage IB, II, or IIIA NSCLC
9 mins; March 09, 2023
CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice
28 mins; March 06, 2023
Jakubowiak Highlights PFS Benefit Seen With KRd Maintenance in Newly Diagnosed Multiple Myeloma
22 mins; March 02, 2023
FDA Approval Insights: Pirtobrutinib in MCL
6 mins; February 27, 2023
Mascarenhas Summarizes Therapeutic Standards and Advances in Myelofibrosis Management
17 mins; February 23, 2023
Camidge and Bauml on Breaking Into Industry From Academia
29 mins; February 20, 2023
FDA Approval Insights: Zanubrutinib in CLL and SLL
14 mins; February 16, 2023
Small and Reagan Review Tumor Lysis Syndrome Risk Factors and Management Strategies
15 mins; February 13, 2023
D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor
10 mins; February 09, 2023
FDA Approval Insights: Tucatinib and Trastuzumab in HER2+ mCRC
9 mins; February 06, 2023
Rosenthal Discusses the Need for Standardized Care in AYA Hodgkin Lymphoma
14 mins; February 02, 2023
Nair Notes the Benefits of Yoga as a Complementary Therapy in Nonmetastatic Breast Cancer
11 mins; January 30, 2023
FDA Approval Insights: Nadofaragene Firadenovec in BCG-Unresponsive NMIBC
12 mins; January 26, 2023
Goetz and Choong Describe the Need for Adjuvant Endocrine Therapy in ER-positive Breast Cancer
13 mins; January 23, 2023
Dy Discusses CEACAM5-Directed and Other Second-Line Treatment Strategies in NSCLC
14 mins; January 19, 2023
Giacchetti Discusses the Convergence of Chronobiology and Oncologic Care in Breast Cancer
11 mins; January 16, 2023
Hilal Highlights BTK Inhibitor Research and Implications of MRD Negativity in CLL
12 mins; January 12, 2023
Camidge and Cetnar Consider the Value of Career Scholarship, Leadership, and Mentorship
32 mins; January 09, 2023
Breast Cancer Experts Review HR+ Treatment Updates From SABCS 2022
25 mins; January 05, 2023
Oppong Emphasizes How Patient Education Can Lower Breast Cancer Surgery Refusal Rates
21 mins; January 02, 2023
Somaiah Shares Insight on the Changing Landscapes of GIST, TGCT, and RAS/RAF-Mutant Tumors
17 mins; December 29, 2022
Rugo Summarizes Developments With Ribociclib and ADCs in HR-Positive Breast Cancer
15 mins; December 26, 2022
Expert and Patient Perspectives on Comprehensive Multiple Myeloma Treatment
20 mins; December 22, 2022
Blum Highlights Implications of CA-125 Levels in Renal Medullary Carcinoma
22 mins; December 19, 2022
FDA Approval Insights: Tremelimumab Plus Durvalumab and Chemotherapy in NSCLC
12 mins; December 15, 2022
Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent
15 mins; December 12, 2022
Brody Previews ASH 2022 Data With Pirtobrutinib, CAR T-cell Therapy, and Glofitamab in MCL
12 mins; December 08, 2022
FDA Approval Insights: Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
17 mins; December 05, 2022
Leone Lays Out Research Needs and Treatment Approaches in Male Breast Cancer
15 mins; December 01, 2022
Florez Discusses Crucial Aspects of Cancer Care Equity and Survivorship
13 mins; November 28, 2022
FDA Approval Insights: Durvalumab Plus Tremelimumab in HCC
18 mins; November 24, 2022
Crane Helps Gynecologic Fellows Deliver Care in a Complicated Time
13 mins; November 21, 2022
Oppong Sheds Light on Racial Disparities in Breast Cancer Diagnosis and Mortality
21 mins; November 17, 2022
FDA Approval Insights: Teclistamab in Relapsed/Refractory Multiple Myeloma
13 mins; November 14, 2022
Lunning Lends Insight on Pivotal Data From Pan Pacific Lymphoma 2022
25 mins; November 10, 2022
Sauter and Hill Talk Through CAR T Cell Sequencing and Access in Lymphomas
22 mins; November 07, 2022
FDA Approval Insights: Futibatinib in FGFR2-Positive Cholangiocarcinoma
11 mins; November 03, 2022
Thymic Cancer Experts Discuss the Latest Data, Need for More Research Funding
22 mins; October 31, 2022
Mikhael and Cole Share Insights on Culturally Relevant Myeloma Care
14 mins; October 27, 2022
FDA Approval Insights: Sodium Thiosulfate in Cisplatin-Treated Pediatric Solid Tumors
15 mins; October 24, 2022
Leukemia Experts Discuss Early Career Growth, Mentorship, and Gender Bias in Academia
47 mins; October 20, 2022
Community Perspectives on Integrating and Interpreting Molecular Testing Results in NSCLC
15 mins; October 17, 2022
FDA Approval Insights: Selpercatinib in RET Fusion–Positive Solid Tumors
18 mins; October 13, 2022
Brentjens on the Next Chapter of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
12 mins; October 10, 2022
Velcheti Discusses Mobile Telehealth-Based Research to Close Cancer Care Gaps
11 mins; October 06, 2022
FDA Approval Insights: Durvalumab Plus Gemcitabine and Cisplatin in Biliary Tract Cancer
8 mins; October 03, 2022
Shepard Discusses Symptoms, Management, and Future Directions in Desmoid Tumors
20 mins; September 29, 2022
Deol on the Importance of a Well-Rounded Fellowship Experience
17 mins; September 26, 2022
Patel Provides Insight Into Post-Transplant Complications in Myeloid Disorders
16 mins; September 22, 2022
FDA Approval Insights: Pemigatinib in FGFR1-Rearranged Myeloid/Lymphoid Neoplasms
10 mins; September 19, 2022
Leal Sheds Light on Symptoms and Treatment of Lambert-Eaton Myasthenic Syndrome
14 mins; September 15, 2022
Elamin Elaborates on Poziotinib in EGFR Exon 20–Mutant NSCLC
10 mins; September 12, 2022
Chen Discusses Diagnosis, Management, and Disparities in Cutaneous T-cell Lymphoma
19 mins; September 08, 2022
FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Low Unresectable or Metastatic Breast Cancer
11 mins; September 05, 2022
Iams and Shah Break Down Lambert-Eaton Myasthenic Syndrome in SCLC and Other Neuroendocrine Cancers
19 mins; September 01, 2022
Bekaii-Saab, George, and von Mehren Discuss Pivotal Findings in GIST, TGCT, and RAS/RAF–Mutated Solid Tumors
25 mins; August 29, 2022
FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Mutant NSCLC
11 mins; August 25, 2022
Petrylak Provides Insight Into Testing, Multidisciplinary Management in Prostate and Bladder Cancer
11 mins; August 22, 2022
Goldberg and Sussman Dissect Disparities in Gastric Cancer Mortality Rates
19 mins; August 18, 2022
FDA Approval Insights: Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
13 mins; August 15, 2022
Katz Considers the Role of Neoadjuvant Chemoradiation in Borderline Resectable Pancreatic Cancer
17 mins; August 11, 2022
Click here to see more
‹ Prev
1
2
3
4
5
6
Next ›
